Comparisons
Ozempic vs Victoza: How the Newer Semaglutide Compares to Liraglutide
If you're exploring GLP-1 medications for weight loss or type 2 diabetes, you've likely come across both Ozempic and Victoza. Both are proven treatments that work similarly in your body, but there are some important differences that might make one a better fit for you than the other. Let's walk through what sets them apart—and what you really need to know to have an informed conversation with your doctor.
What Are Ozempic and Victoza?
Both Ozempic and Victoza belong to a class of medications called GLP-1 receptor agonists. These drugs mimic a natural hormone in your body called glucagon-like peptide-1, which helps regulate blood sugar, slows digestion, and reduces appetite.
Victoza (liraglutide) was approved by the FDA in 2010 and has been around longer. It's a once-daily injection that's been a workhorse in diabetes care for over a decade. Ozempic (semaglutide) came along in 2017 as a newer generation of GLP-1 medication, offering once-weekly dosing and some additional benefits we'll discuss.
Think of them as cousins in the same medication family—similar in many ways, but with distinct personalities.
The Big Differences: Dosing and Convenience
How Often You Inject
This is often the first thing people notice. Victoza requires a daily injection, while Ozempic is taken just once a week. For many people, this difference alone is significant. Remembering a daily medication can be challenging, especially when life gets busy. A weekly injection means fewer needle sticks and less disruption to your routine.
That said, some people actually prefer the daily routine of Victoza. It can feel more manageable to make small adjustments, and if you experience side effects, they may feel less intense spread across daily doses rather than in the days following a larger weekly dose.
Dosing Flexibility
Victoza comes in doses ranging from 0.6 mg to 1.8 mg daily, with most people working up to the full 1.8 mg dose for weight loss. Ozempic starts at 0.25 mg weekly (a starter dose) and typically increases to 0.5 mg, 1 mg, or even 2 mg weekly depending on your response and tolerance.
The weekly dosing of Ozempic can make dose adjustments feel more significant, while Victoza's daily dosing allows for more frequent fine-tuning if needed.
Effectiveness: Weight Loss and Blood Sugar Control
For Type 2 Diabetes
Both medications are FDA-approved for type 2 diabetes and effectively lower A1C levels (your three-month average blood sugar). In head-to-head studies, Ozempic tends to lower A1C slightly more than Victoza—typically by an additional 0.4 to 0.5 percentage points. While that might sound small, it can be meaningful for some people working toward tighter blood sugar control.
For Weight Loss
Here's where the differences become more pronounced. Clinical trials show that people taking Ozempic lose more weight on average than those taking Victoza. In studies, Ozempic users lost approximately 12-14 pounds over 6-12 months at standard diabetes doses, while Victoza users typically lost around 5-8 pounds in the same timeframe.
At higher doses (which are used in Wegovy, the weight-loss formulation of semaglutide), weight loss can be even more significant—often 15% or more of body weight. Victoza also has a higher-dose weight-loss formulation called Saxenda (3 mg daily), which produces weight loss results closer to 8-10% of body weight.
It's important to remember that these are averages. Individual responses vary widely, and factors like diet, exercise, sleep, and stress all play important roles in your results.
Side Effects: What to Expect
Because they work in similar ways, Ozempic and Victoza share many of the same potential side effects. The most common ones include nausea, diarrhea, constipation, vomiting, and stomach discomfort. These typically improve over the first few weeks as your body adjusts.
Some people report that nausea feels more intense with Ozempic, possibly because the weekly dose delivers a larger amount of medication at once. Others find the daily dosing of Victoza keeps their stomach more consistently unsettled. There's no way to predict which you'll tolerate better without trying.
Both medications carry similar warnings about rare but serious risks, including pancreatitis, gallbladder problems, and thyroid C-cell tumors (seen in animal studies). Neither should be used if you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.
Cost Considerations
Without insurance, both Ozempic and Victoza are expensive—often $900 to $1,300 per month at retail prices. Insurance coverage varies widely, and both medications may require prior authorization.
Some people find that one is better covered by their plan than the other, which can be a deciding factor. Compounded semaglutide (the same active ingredient as Ozempic) is also available through telehealth providers at a significantly lower cost, which has made this medication more accessible for people using it primarily for weight loss.
Which One Is Right for You?
The honest answer is: it depends on your individual situation, preferences, and how your body responds.
Ozempic might be a better choice if you want once-weekly dosing for convenience, are looking for potentially greater weight loss, or want the most current generation of GLP-1 medication.
Victoza might suit you better if you prefer daily dosing that allows for more frequent adjustments, want a medication with a longer track record, or find that your insurance covers it more favorably.
Neither choice is wrong—both are effective, well-studied medications that have helped millions of people improve their metabolic health.
For Women
Women may experience GLP-1 side effects somewhat differently than men, often reporting more persistent nausea, especially during the first month. Hormonal fluctuations throughout your menstrual cycle can also affect how you tolerate these medications. Some women find that starting at the lowest possible dose and increasing very gradually helps minimize digestive symptoms. If you're planning pregnancy, it's important to discuss timing with your doctor, as both medications should be discontinued before conception.
For Men
Men typically tolerate higher doses of GLP-1 medications more quickly than women and may see blood sugar improvements slightly faster, though weight loss rates are generally similar between genders. If you're already physically active or have significant muscle mass, combining these medications with adequate protein intake is particularly important to preserve lean body mass during weight loss.
From the Ozari Care Team
If you're switching from Victoza to Ozempic or vice versa, expect a transition period of about two weeks where your body adjusts to the new medication schedule. Don't be surprised if side effects resurface briefly—this is normal and usually temporary. Keep your provider informed about how you're feeling during the switch so they can support you through the transition.
Ready to Start Your GLP-1 Journey?
At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.
Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026